Prosight Management »

10x Genomics Inc Cl A shares owned by Prosight Management

Quarter-by-quarter ownership of 10x Genomics Inc Cl A (TXG) shares owned by Prosight Management from 13F filings

Historical chart of Prosight Management investment in 10x Genomics Inc Cl A

Tip: Access up to 7 years of quarterly data

All positions including 10x Genomics Inc Cl A held by Prosight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 10x Genomics Inc Cl A by Prosight Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.1M 30k 37.53

More positions owned by Prosight Management

Shattuck Labs (STTK)
Adc Therapeutics Sa SHS (ADCT)
Galapagos Nv Spon Adr (GLPG)
Meiragtx Holdings (MGTX)
Kura Oncology (KURA)
Roivant Sciences SHS (ROIV)
Bridgebio Pharma (BBIO)
Cytokinetics Com New (CYTK)
Medtronic SHS (MDT)
Orthopediatrics Corp. (KIDS)
Mirum Pharmaceuticals (MIRM)
Guardant Health (GH)
Kelly Svcs Cl A (KELYA)
Abcellera Biologics (ABCL)
Erasca (ERAS)

View all positions for Prosight Management

Top funds holding 10x Genomics Inc Cl A

ARK Investment Management
Vanguard Group
BlackRock
BlackRock
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Morgan Stanley
Generation Investment Management
Citadel Advisors
T. Rowe Price Associates
Brown Capital Management
T. Rowe Price Investment Management
Venrock Management VI
Geode Capital Management
State Street Corporation

View all funds holding 10x Genomics Inc Cl A